CVS Health Files 8-K
Ticker: CVS · Form: 8-K · Filed: Dec 5, 2024 · CIK: 64803
Sentiment: neutral
Topics: 8-K, disclosure, corporate-event
Related Tickers: CVS
TL;DR
CVS filed an 8-K on 12/5 for an event on 12/3. Details TBD.
AI Summary
CVS Health Corporation filed an 8-K on December 5, 2024, reporting an event that occurred on December 3, 2024. The filing is categorized under 'Other Events' and 'Financial Statements and Exhibits'. Specific details regarding the nature of the event or any financial implications are not provided in this excerpt.
Why It Matters
This filing indicates a material event has occurred for CVS Health, requiring public disclosure. Investors should look for subsequent filings or press releases for details.
Risk Assessment
Risk Level: low — The filing itself is a standard disclosure and does not inherently present a risk, but the underlying event it reports could have implications.
Key Numbers
- 001-01011 — SEC File Number (Identifies the specific filing for CVS Health)
- 05-0494040 — IRS Employer Identification No. (Tax identification for CVS Health)
Key Players & Entities
- CVS HEALTH Corp (company) — Registrant
- 0000064803 (company) — Central Index Key
- December 3, 2024 (date) — Earliest event reported
- December 5, 2024 (date) — Filing date
- One CVS Drive, Woonsocket, Rhode Island 02895 (address) — Principal executive offices
FAQ
What specific event is being reported under 'Other Events'?
The provided excerpt does not specify the nature of the 'Other Events' being reported.
When did the earliest reported event occur?
The earliest reported event occurred on December 3, 2024.
What is the filing date of this 8-K report?
This 8-K report was filed on December 5, 2024.
What is the principal executive office address for CVS Health?
The principal executive office is located at One CVS Drive, Woonsocket, Rhode Island 02895.
What is the SEC file number for CVS Health?
The SEC file number for CVS Health is 001-01011.
Filing Stats: 882 words · 4 min read · ~3 pages · Grade level 12.9 · Accepted 2024-12-04 18:53:01
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share CVS New York Stock Exchan
- $2,250,000,000 — d to issue and sell to the Underwriters $2,250,000,000 aggregate principal amount of its 7.000
- $750,000,000 — eries A Junior Subordinated Notes") and $750,000,000 aggregate principal amount of its 6.750
- $2,963,075,700 — mpany, are expected to be approximately $2,963,075,700. A copy of the Underwriting Agreement i
Filing Documents
- d910747d8k.htm (8-K) — 29KB
- d910747dex11.htm (EX-1.1) — 158KB
- g910747g1204104159153.jpg (GRAPHIC) — 1KB
- 0001193125-24-270867.txt ( ) — 344KB
- cvs-20241203.xsd (EX-101.SCH) — 3KB
- cvs-20241203_lab.xml (EX-101.LAB) — 17KB
- cvs-20241203_pre.xml (EX-101.PRE) — 11KB
- d910747d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits . The exhibits to this Current Report on Form 8-K are as follows: INDEX TO EXHIBITS 1.1 Underwriting Agreement, dated December 3, 2024, between CVS Health Corporation and Barclays Capital Inc., Citigroup Global Markets Inc. and Goldman Sachs & Co. LLC, as representatives of the several Underwriters named in Schedule I thereto. 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CVS HEALTH CORPORATION Date: December 4, 2024 By: /s/ Thomas F. Cowhey Thomas F. Cowhey Executive Vice President and Chief Financial Officer